Matches in SemOpenAlex for { <https://semopenalex.org/work/W2411888917> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2411888917 endingPage "52" @default.
- W2411888917 startingPage "144" @default.
- W2411888917 abstract "Hyperphosphataemia, calcitriol deficency and secondary hyperparathyroidism (sHPT) are common complications in end-stage chronic kidney diseases (CKD). Fibroblast Growth Factor 23 (FGF-23) is a phosphaturic peptide, secreted by the osteoblast precursors, that also inhibits renal 1-alpha-hydroxylase activitiy and tubular phosphate reabsorption by the inhibition of sodium-dependant renal phosphate transport (Na-Pi-IIa). Consequences are a decreaese of serum 1,25 dihydroxyvitamin D3 and phosphaturia. Therefore, FGF-23 plays a role in hyperphosphataemia in association with CKD and may be involved in the pathogenesis of sHPT. Increased FGF-23 may contribute to maintaining a normal serum phoshpate level in face of a processing CKD, but if the creatinine clearance is reduced to lower than 30 ml/min the capacity of this regulative mechanism ends and hyperphosphataemia results. In our investigation of end-stage renal diseases markedly increased serum FGF-23, associated with hyperphosphataemia, phosphaturia and decreased serum calcitriol and sHPT, were found. Furthermore preanalytical testing for the stability of FGF-23 was performed by comparing samples which were stored at -20 degrees C with samples that have been stored for 6 days at +4 degrees C. The simultaneous investigation of serum and EDTA plasma FGF-23 certifies the advantage of EDTA plasma in subjects with an intact renal function." @default.
- W2411888917 created "2016-06-24" @default.
- W2411888917 creator A5003361194 @default.
- W2411888917 creator A5011726114 @default.
- W2411888917 creator A5025854844 @default.
- W2411888917 creator A5028429315 @default.
- W2411888917 creator A5038592896 @default.
- W2411888917 creator A5077648412 @default.
- W2411888917 creator A5090549729 @default.
- W2411888917 date "2009-01-01" @default.
- W2411888917 modified "2023-09-26" @default.
- W2411888917 title "Evaluation of human fibroblast growth factor 23 (FGF-23) C-terminal and intact enzyme-linked immunosorbent-assays in end-stage renal disease patients." @default.
- W2411888917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19462937" @default.
- W2411888917 hasPublicationYear "2009" @default.
- W2411888917 type Work @default.
- W2411888917 sameAs 2411888917 @default.
- W2411888917 citedByCount "4" @default.
- W2411888917 countsByYear W24118889172015 @default.
- W2411888917 countsByYear W24118889172020 @default.
- W2411888917 countsByYear W24118889172021 @default.
- W2411888917 countsByYear W24118889172022 @default.
- W2411888917 crossrefType "journal-article" @default.
- W2411888917 hasAuthorship W2411888917A5003361194 @default.
- W2411888917 hasAuthorship W2411888917A5011726114 @default.
- W2411888917 hasAuthorship W2411888917A5025854844 @default.
- W2411888917 hasAuthorship W2411888917A5028429315 @default.
- W2411888917 hasAuthorship W2411888917A5038592896 @default.
- W2411888917 hasAuthorship W2411888917A5077648412 @default.
- W2411888917 hasAuthorship W2411888917A5090549729 @default.
- W2411888917 hasConcept C114276007 @default.
- W2411888917 hasConcept C124490489 @default.
- W2411888917 hasConcept C126322002 @default.
- W2411888917 hasConcept C134018914 @default.
- W2411888917 hasConcept C159641895 @default.
- W2411888917 hasConcept C185592680 @default.
- W2411888917 hasConcept C2776079296 @default.
- W2411888917 hasConcept C2778653478 @default.
- W2411888917 hasConcept C2778838027 @default.
- W2411888917 hasConcept C2781208988 @default.
- W2411888917 hasConcept C519063684 @default.
- W2411888917 hasConcept C71924100 @default.
- W2411888917 hasConceptScore W2411888917C114276007 @default.
- W2411888917 hasConceptScore W2411888917C124490489 @default.
- W2411888917 hasConceptScore W2411888917C126322002 @default.
- W2411888917 hasConceptScore W2411888917C134018914 @default.
- W2411888917 hasConceptScore W2411888917C159641895 @default.
- W2411888917 hasConceptScore W2411888917C185592680 @default.
- W2411888917 hasConceptScore W2411888917C2776079296 @default.
- W2411888917 hasConceptScore W2411888917C2778653478 @default.
- W2411888917 hasConceptScore W2411888917C2778838027 @default.
- W2411888917 hasConceptScore W2411888917C2781208988 @default.
- W2411888917 hasConceptScore W2411888917C519063684 @default.
- W2411888917 hasConceptScore W2411888917C71924100 @default.
- W2411888917 hasIssue "3-4" @default.
- W2411888917 hasLocation W24118889171 @default.
- W2411888917 hasOpenAccess W2411888917 @default.
- W2411888917 hasPrimaryLocation W24118889171 @default.
- W2411888917 hasRelatedWork W161031801 @default.
- W2411888917 hasRelatedWork W167885308 @default.
- W2411888917 hasRelatedWork W1726101972 @default.
- W2411888917 hasRelatedWork W1977645780 @default.
- W2411888917 hasRelatedWork W1998100845 @default.
- W2411888917 hasRelatedWork W2003490678 @default.
- W2411888917 hasRelatedWork W2021852822 @default.
- W2411888917 hasRelatedWork W2061453367 @default.
- W2411888917 hasRelatedWork W2069486067 @default.
- W2411888917 hasRelatedWork W2094551185 @default.
- W2411888917 hasRelatedWork W2095948376 @default.
- W2411888917 hasRelatedWork W2098828778 @default.
- W2411888917 hasRelatedWork W2106867280 @default.
- W2411888917 hasRelatedWork W2107420262 @default.
- W2411888917 hasRelatedWork W2129739601 @default.
- W2411888917 hasRelatedWork W2335827198 @default.
- W2411888917 hasRelatedWork W2576527809 @default.
- W2411888917 hasRelatedWork W3088241767 @default.
- W2411888917 hasRelatedWork W36137382 @default.
- W2411888917 hasRelatedWork W72407264 @default.
- W2411888917 hasVolume "55" @default.
- W2411888917 isParatext "false" @default.
- W2411888917 isRetracted "false" @default.
- W2411888917 magId "2411888917" @default.
- W2411888917 workType "article" @default.